发明名称 |
Intraoral dosing method of administering (+)- alpha -4-(dimethylamino)-3-methyl-1,2-diphenyl-2-butanolpropionate |
摘要 |
A method of therapeutically administering certain BZ1 specific trifluorobenzodiazepines in order to maximize the BZ1 effects and minimize the BZ2 effects on the human central nervous system in order to maximize the anti-anxiety, anticonvulsant and hypnotic effects and minimize the ataxic and incoordination effects of the drug. Also, a method of sublingual administration of trifluorobenzodiazepines and certain other compounds in order to decrease unwanted dealkylated metabolites.
|
申请公布号 |
US5354780(A) |
申请公布日期 |
1994.10.11 |
申请号 |
US19930038911 |
申请日期 |
1993.03.29 |
申请人 |
ELLINWOOD, EVERETT H.;GUPTA, SAMIR K. |
发明人 |
ELLINWOOD, EVERETT H.;GUPTA, SAMIR K. |
分类号 |
A61K31/137;A61K31/496;A61K31/55;A61K31/5513;(IPC1-7):A61K31/135 |
主分类号 |
A61K31/137 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|